With more than 22 years in practice, Jonn Beeson has advised on M&A transactions with an aggregate value in excess of $225 billion. His practice focuses on mergers and acquisitions, divestitures, takeovers, capital raising, securities transactions, and corporate governance issues. Jonn represents large publicly traded corporations, middle market private companies, and start-up companies and is most active in the life sciences (including pharmaceuticals, medical devices, and biologics), technology, and software industries.
4:00 PM - 4:45 PM (EDT)
Tuesday, June 15
Financial performance of innovation in the life sciences economy—Tracking the IPO Class through twists and turns
The IPO Class has grown over the last 8 years and continued through a COVID-19 inflection. This…